{"id":415,"date":"2024-09-30T14:11:21","date_gmt":"2024-09-30T14:11:21","guid":{"rendered":"https:\/\/naujienosversle.lt\/index.php\/2024\/09\/30\/vienoje-isikurusi-flinn-ai-uzsitikrina-10-mln-euru-kad-butu-galima-automatizuoti-kokybe-ir-teises-aktu-laikymasi-medicinos-technologiju-srityje\/"},"modified":"2024-09-30T14:11:21","modified_gmt":"2024-09-30T14:11:21","slug":"vienoje-isikurusi-flinn-ai-uzsitikrina-10-mln-euru-kad-butu-galima-automatizuoti-kokybe-ir-teises-aktu-laikymasi-medicinos-technologiju-srityje","status":"publish","type":"post","link":"https:\/\/naujienosversle.lt\/index.php\/2024\/09\/30\/vienoje-isikurusi-flinn-ai-uzsitikrina-10-mln-euru-kad-butu-galima-automatizuoti-kokybe-ir-teises-aktu-laikymasi-medicinos-technologiju-srityje\/","title":{"rendered":"Vienoje \u012fsik\u016brusi \u201eFlinn.ai\u201c u\u017esitikrina 10 mln. eur\u0173, kad b\u016bt\u0173 galima automatizuoti kokyb\u0119 ir teis\u0117s akt\u0173 laikym\u0105si medicinos technologij\u0173 srityje"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<p><span style=\"font-weight: 400;\">Flinn.ai<\/span><span style=\"font-weight: 400;\">pirmaujanti programin\u0117s \u012frangos sprendim\u0173, skirt\u0173 medicinos technologij\u0173 \u012fmoni\u0173 atitikties proces\u0173 automatizavimui ir optimizavimui, tiek\u0117ja, vos per 18 m\u0117nesi\u0173 pritrauk\u0117 10 mln. \u201eCherry Ventures\u201c vadovavo dabartiniam finansavimo etapui. \u0160ia investicija Flinn.ai planuoja paspartinti savo rinkos ir produkt\u0173 pl\u0117tr\u0105, o ypa\u010d toliau tobulinti dirbtiniu intelektu pagr\u012fstus modulius, skirtus kokyb\u0117s valdymui ir reikalavim\u0173 laikymuisi. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Be Cherry Ventures, Flinne dalyvavo esami investuotojai, tokie kaip Speedinvest ir SquareOne, taip pat nema\u017eai \u017einom\u0173 verslo angel\u0173, \u012fskaitant Matthias\u0105 Weber\u012f (buvus\u012f Leica Biosystems prezident\u0105) ir Michael\u0105 Reiterman\u0105 (buvus\u012f Siemens Diagnostics generalin\u012f direktori\u0173). ai investicij\u0173 raundas. <\/span><\/p>\n<p><i><span style=\"font-weight: 400;\">\u201eM\u016bs\u0173 AI sprendimai si\u016blo did\u017eiul\u012f potencial\u0105 \u017eymiai pagerinti esam\u0173 medicinos prietais\u0173 kokyb\u0119. Padedami Cherry Ventures ir kit\u0173 m\u016bs\u0173 investuotoj\u0173, galime dar labiau paspartinti savo vizij\u0105, kad auk\u0161tos kokyb\u0117s sveikatos prie\u017ei\u016bros produktai b\u016bt\u0173 prieinami visiems.<\/span><\/i><span style=\"font-weight: 400;\">  paai\u0161kino Bastianas Krapingeris-R\u00fctheris, vienas i\u0161 Flinn.ai \u012fk\u016br\u0117j\u0173 ir generalinis direktorius.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201eFlinn.ai\u201c programin\u0117s \u012frangos kaip paslaugos (SaaS) sprendimai leid\u017eia MedTech gamintojams de\u0161imt kart\u0173 efektyvinti atitikties procesus, integruojant dirbtinio intelekto automatizavim\u0105 \u012f duomen\u0173 apdorojim\u0105, vertinim\u0105 ir ataskait\u0173 teikim\u0105. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Filipas Damesas, Cherry Ventures partneris, pabr\u0117\u017e\u0117 investavimo \u012f \u012fmon\u0119 svarb\u0105: <\/span><i><span style=\"font-weight: 400;\">\u201eInvestavome \u012f Flinn.ai, nes manome, kad \u012fmon\u0117s novatori\u0161kas po\u017ei\u016bris yra unikalioje pad\u0117tyje, kad gal\u0117t\u0173 pasinaudoti besivystan\u010dia MedTech aplinka. Kadangi taisykl\u0117s tampa vis grie\u017etesn\u0117s, Flinn.ai diferencijuotas produkt\u0173 pasi\u016bla yra pasirengusi padaryti savo \u017eenkl\u0105 nepakankamai aptarnaujamoje rinkoje. Mes, Cherry, d\u017eiaugiam\u0117s gal\u0117dami dirbti su komanda, kuri sujungia gili\u0105 pramon\u0117s patirt\u012f ir pa\u017eangiausias technologijas, tod\u0117l Flinn.ai yra idealus trikdytojas \u0161ioje naujoje medicinos technologij\u0173 eroje.<\/span><\/i><\/p>\n<p><span style=\"font-weight: 400;\">Vis sud\u0117ting\u0117jant reguliavimo reikalavimams, ypa\u010d \u012fvedant ES medicinos prietais\u0173 reglament\u0105 (MDR), medicinos technologij\u0173 gamintojai susiduria su did\u017eiuliais i\u0161\u0161\u016bkiais. D\u0117l nauj\u0173 taisykli\u0173 labai padid\u0117jo atitikties s\u0105naudos, tod\u0117l daugelis \u012fmoni\u0173 buvo priverstos atsisakyti ma\u017eiau pelning\u0173 ni\u0161ini\u0173 produkt\u0173 arba pasitraukti i\u0161 ma\u017eiau pelning\u0173 rink\u0173. \u0160i pl\u0117tra kelia pavoj\u0173 svarbi\u0173 medicinos produkt\u0173, pvz., defibriliatori\u0173 k\u016bdikiams, prieinamumui visame pasaulyje ir didina kli\u016btis naujiems novatoriams patekti \u012f rink\u0105. \u0160tai kod\u0117l tokios \u012fmon\u0117s kaip Erbe Elektromedizin GmbH pasitiki Flinn.ai.<\/span><\/p>\n<p><i><span style=\"font-weight: 400;\">\u201eFlinn.ai produkt\u0173 k\u016brimas padar\u0117 mums didel\u012f \u012fsp\u016bd\u012f! Nuo pat prad\u017ei\u0173 jie atid\u017eiai klaus\u0117si ir tiksliai nustat\u0117, kurie sprendimai ne tik pagerint\u0173 m\u016bs\u0173 procesus, bet ir juos supaprastint\u0173. Geras pavyzdys yra saugos duomen\u0173 bazi\u0173 steb\u0117jimo programin\u0117s \u012frangos \u012fdiegimas, kuris pad\u0117jo mums automatizuoti ir pagreitinti \u0161ias pasikartojan\u010dias ir monotoni\u0161kas u\u017eduotis. Tai leido mums ne tik suma\u017einti personalo i\u0161laidas, bet vis\u0173 pirma padidinti m\u016bs\u0173 darbuotoj\u0173 pasitenkinim\u0105. Dabar jie gali atsiduoti \u012fdomesn\u0117ms ir prid\u0117tin\u0119 vert\u0119 kurian\u010dioms u\u017eduotims, u\u017euot skirdami laiko kopijavimo ir \u012fklijavimo veiklai.<\/span><\/i><span style=\"font-weight: 400;\">  komentavo Helmutas Schereris, \u201eErbe Elektromedizin GmbH\u201c vyriausiasis technologij\u0173 direktorius. <\/span><\/p>\n<div class=\"td-a-ad id_bottom_ad \"><span class=\"td-adspot-title\">&#8211; Reklama &#8211;<\/span><\/div>\n<\/div>\n<p><script>\n        !function(f,b,e,v,n,t,s)\n        {if(f.fbq)return;n=f.fbq=function(){n.callMethod?\n            n.callMethod.apply(n,arguments):n.queue.push(arguments)};\n            if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0';\n            n.queue=();t=b.createElement(e);t.async=!0;\n            t.src=v;s=b.getElementsByTagName(e)(0);\n            s.parentNode.insertBefore(t,s)}(window, document,'script',\n            'https:\/\/connect.facebook.net\/en_US\/fbevents.js');\n        fbq('init', '154586475232058');\n        fbq('track', 'PageView');\n    <\/script><br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.eu-startups.com\/2024\/09\/vienna-based-flinn-ai-secures-e10-million-to-automate-quality-and-regulatory-medtech-compliance\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Flinn.aipirmaujanti programin\u0117s \u012frangos sprendim\u0173, skirt\u0173 medicinos technologij\u0173 \u012fmoni\u0173 atitikties proces\u0173 automatizavimui ir optimizavimui, tiek\u0117ja, vos per 18 m\u0117nesi\u0173 pritrauk\u0117 10 mln. \u201eCherry Ventures\u201c vadovavo dabartiniam finansavimo etapui. \u0160ia investicija Flinn.ai planuoja paspartinti savo rinkos ir produkt\u0173 pl\u0117tr\u0105, o ypa\u010d toliau tobulinti dirbtiniu intelektu pagr\u012fstus modulius, skirtus kokyb\u0117s valdymui ir reikalavim\u0173 laikymuisi. Be Cherry Ventures, Flinne&#8230;<\/p>\n","protected":false},"author":1,"featured_media":416,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[6],"tags":[613,610,159,57,608,609,53,108,611,614,615,56,296,616,612,55,214],"class_list":["post-415","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-europos-verslo-naujienos","tag-aktu","tag-automatizuoti","tag-butu","tag-euru","tag-flinn-ai","tag-galima","tag-isikurusi","tag-kad","tag-kokybe","tag-laikymasi","tag-medicinos","tag-mln","tag-srityje","tag-technologiju","tag-teises","tag-uzsitikrina","tag-vienoje"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/posts\/415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/comments?post=415"}],"version-history":[{"count":0,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/posts\/415\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/media\/416"}],"wp:attachment":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/media?parent=415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/categories?post=415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/tags?post=415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}